KNSAKiniksa Pharmaceuticals International, plcvs its industry peers
A metric-by-metric comparison of Kiniksa Pharmaceuticals International, plc against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KNSAEsta | $5.8B#4 | 83.9x#3 | 9.6x#2 | 8.6x#1 | 60.1%#6 | 236.6%#5 | 11.4%#5 | 9.7%#5 | — | — | — | — |
| IVA | $871M#5 | — | — | — | — | — | — | — | — | — | 36.3%#1 | — |
| IXHL | $36M#7 | 0.1x#2 | 0.5x#1 | 414.6x#2 | 616.7%#1 | -154.0%#8 | -27661.6%#8 | -62.3%#8 | -521.0%#7 | — | — | — |
| JAGX | — | 0.0x#1 | — | — | -1.5%#7 | -37.6%#6 | -398.8%#6 | -0.3%#7 | -183.3%#5 | — | -98.5%#2 | — |
| KAYS | — | — | — | — | -96.4%#9 | -229.3%#9 | -28343.5%#9 | — | -846.8%#8 | — | — | — |
| KMDA | $422M#6 | — | — | — | — | — | — | — | — | — | — | — |
| KPHMW | — | — | — | — | -100.0%#10 | -401.4%#10 | — | -0.1%#6 | -393.9%#6 | — | — | — |
| KZIA | $10.1B#2 | — | — | — | — | — | — | — | — | — | — | — |
| LEGN | $7.1B#3 | — | — | — | — | — | — | — | — | — | — | — |
| LGNDZ | — | — | — | — | 60.4%#2 | 3186.6%#1 | 15.3%#1 | 12.5%#1 | 3.5%#1 | — | — | — |
| LGNXZ | — | — | — | — | 60.4%#2 | 3186.6%#1 | 15.3%#1 | 12.5%#1 | 3.5%#1 | — | — | — |
| LGNYZ | — | — | — | — | 60.4%#2 | 3186.6%#1 | 15.3%#1 | 12.5%#1 | 3.5%#1 | — | — | — |
| LGNZZ | — | — | — | — | 60.4%#2 | 3186.6%#1 | 15.3%#1 | 12.5%#1 | 3.5%#1 | — | — | — |
| LGVN | $19.2B#1 | — | 1197.3x#3 | 16004.6x#3 | -49.9%#8 | -42.1%#7 | -1942.2%#7 | -141.7%#9 | -5584.4%#9 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-08-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice